NCT06864117

Brief Summary

To demonstrate the feasibility of a pressure-flow study using a urinary condom with drainage tube in the sitting and lying position in everyday clinical practice and the comparability of the measured values with the "conventional" pressure-flow studies according to the ICS standard with regard to the diagnosis of outlet obstruction in men.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
23mo left

Started Feb 2025

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Feb 2025Feb 2028

First Submitted

Initial submission to the registry

February 25, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

February 28, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 7, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2028

Last Updated

March 7, 2025

Status Verified

March 1, 2025

Enrollment Period

3 years

First QC Date

February 25, 2025

Last Update Submit

March 3, 2025

Conditions

Keywords

obstructionurodynamics

Outcome Measures

Primary Outcomes (13)

  • First sensation of filling, FSF [mL]

    measured during storage phase

    Periprocedural

  • First desire to void, FDV [mL]

    measured during storage phase

    Periprocedural

  • Strong desire to void, SDV [mL]

    measured during storage phase

    Periprocedural

  • Pdet(S) [cmH2O]

    Maximum detrusor pressure, measured during storage phase

    Periprocedural

  • Electromyography pelvic floor EMG [μV] during storage phase

    Periprocedural

  • Filling volume [mL] during storage phase

    Periprocedural

  • Compl [mL/cmH2O]

    Compliance, measured during storage phase

    Periprocedural

  • Maximum detrusor pressure during the voiding phase (Pdet(E) [cmH2O])

    Periprocedural

  • Detrusor pressure at maximum flow rate (PdetQmax [cmH2O])

    measured during voiding phase

    Periprocedural

  • Maximum flow rate (Qmax [mL/s]) during voiding phase

    Periprocedural

  • Electromyography pelvic floor (EMG [μV]) during voiding phase

    Periprocedural

  • Flow volume [mL] during voiding phase

    Periprocedural

  • Residual urine volume (post void residual, PVR [mL])

    Periprocedural

Study Arms (2)

Group A: sitting, lying down(s/l)

OTHER
Other: Body position during urodynamics

Goup B: lying down, sitting (l/s)

OTHER
Other: Body position during urodynamics

Interventions

The group defines the body position in which the first and second measurements are taken. Group A: sitting, lying down (s/l). Group B: lying down, sitting (l/s). According to the ICS standard, the third measurement is always taken in a sitting position.

Goup B: lying down, sitting (l/s)Group A: sitting, lying down(s/l)

Eligibility Criteria

Age18 Years - 90 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Genotype and phenotype XY
  • Age between 18 and 90 years
  • Signed informed consent form
  • Ability to understand and follow the study procedures and understand the consent form
  • possibility ti carry out out the necessary urodynamics as part of the regular clinical examination
  • assessment of neurogenic and/or non-neurogenic (idiopathic) bladder dysfunction
  • Spontaneous micturition in a sitting position is possible

You may not qualify if:

  • Patients with assistance/patients under guardianship
  • Patients with latex allergy or cross-allergy (banana, kiwi, fig, avocado)
  • No spontaneous movement possible in a sitting position
  • Sitting position not possible due to lack of trunk stability/circulatory problems
  • Intravesical Botox injection during the last 9 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Bites and Stings

Condition Hierarchy (Ancestors)

PoisoningChemically-Induced DisordersWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2025

First Posted

March 7, 2025

Study Start

February 28, 2025

Primary Completion (Estimated)

February 28, 2028

Study Completion (Estimated)

February 28, 2028

Last Updated

March 7, 2025

Record last verified: 2025-03